Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

434
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
434
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

269
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
269
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

241
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
241
Survival Curves01:18

Survival Curves

283
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
283
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

370
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
370
Actuarial Approach01:20

Actuarial Approach

123
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
123

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Perfusion With Methylene Blue on Perioperative Bleeding in Simultaneous Pancreas and Kidney Transplantation: A Randomized Control Trial.

Transplantation direct·2026
Same author

Late Presentation of de Novo Proliferative Glomerulonephritis With Monoclonal IgG Deposits in a Renal Allograft: A Rare Case With an Unusual Clinical Course.

Nephrology (Carlton, Vic.)·2026
Same author

Estimating tumour immune infiltration: methodological convergence across histology and spatial technologies.

Briefings in bioinformatics·2026
Same author

Identifying strategies to improve life participation in children with chronic kidney disease: report from multinational SONG workshops.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Longitudinal Assessment of Health-Related Quality of Life in Adults with CKD.

Kidney360·2025
Same author

Comparison of carbon emissions, water use, and dialysis waste between incremental and full-dose peritoneal dialysis: A cohort study.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2025

Related Experiment Video

Updated: Sep 3, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K

SurvBenchmark: comprehensive benchmarking study of survival analysis methods using both omics data and clinical data.

Yunwei Zhang1,2, Germaine Wong3,4,5, Graham Mann6,7

  • 1School of Mathematics and Statistics, The University of Sydney, Sydney 2006, Australia.

Gigascience
|July 30, 2022
PubMed
Summary

Survival analysis models for clinical and omics data show varied performance. A comprehensive benchmark highlights the need for multiple metrics to assess model predictability, stability, and flexibility for accurate survival time predictions.

Keywords:
machine learningsurvival analysissurvival prediction

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K

Related Experiment Videos

Last Updated: Sep 3, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K

Area of Science:

  • Statistics
  • Biostatistics
  • Machine Learning

Background:

  • Survival analysis is crucial for time-to-event data, but model performance evaluation is often limited.
  • Existing comparisons primarily use clinical data and focus on prediction accuracy, neglecting censored omics data.
  • Current methods for omics data often involve time binarization and classification, potentially losing information.

Purpose of the Study:

  • To develop and present SurvBenchmark, a systematic framework for evaluating survival models.
  • To compare classical and machine learning survival models using both clinical and omics data.
  • To assess models based on multiple performance metrics beyond just prediction accuracy.

Main Methods:

  • Developed SurvBenchmark, a systematic comparison design.
  • Evaluated 20 survival models, including Cox and machine learning approaches, across 16 diverse datasets (clinical and omics).
  • Assessed model performance using predictability, stability, flexibility, and computational efficiency.

Main Results:

  • Model performance significantly varies across different datasets and chosen evaluation metrics.
  • No single model consistently outperformed others across all scenarios.
  • Highlighting the critical importance of employing multiple performance metrics for a balanced assessment.

Conclusions:

  • A multi-metric evaluation is essential for a comprehensive understanding of survival model performance.
  • Findings offer practical guidance for selecting appropriate survival analysis methods in translational research.
  • Identified key areas for future research in survival modeling techniques and benchmarking strategies.